Eli Lilly's stock dipped after drug trial results, but strong Q2 2025 earnings and market position make it a strong buy. Read ...

Eli Lilly says their obesity pill led to more than 12% weight loss in closely watched late-stage trial, paving way for ...

On August 9, Fundstrat’s Tom Lee appeared on CNBC to discuss the current state of the market and the potential for further ...

A new weight loss pill has been shown to help slimmers lose around 12 per cent of their body weight over 72 weeks. Alongside ...

A London-based consultant plastic and cosmetic surgeon, has warned of a mistake those on weight loss jabs can make that could ...

Wall Street logged its best week since late June, rebounding from a weak July jobs report on Monday and boosted by strong ...

Stocks are rising on Wall Street, even as President Donald Trump’s latest tariffs kicked into effect on dozens of countries ...

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.